Approval · Notice of Compliance 21043 · 2018
ERLEADA: Notice of Compliance 21043
Issued July 3, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21043
- Date
- July 3, 2018
- Company
- Janssen Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ERLEADA | 02478374 | Marketed |
Medicinal ingredients
- APALUTAMIDE 60 MG per TAB